| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/14/2023 | 4.5% | Barclays | $14 → $18 | Maintains | Equal-Weight |
| 07/12/2023 | 21.92% | Goldman Sachs | → $21 | Initiates Coverage On | → Buy |
| 06/27/2023 | 21.92% | Lake Street | → $21 | Initiates Coverage On | → Buy |
| 06/08/2023 | 21.92% | Craig-Hallum | → $21 | Initiates Coverage On | → Buy |
| 05/09/2023 | -12.92% | JP Morgan | → $15 | Initiates Coverage On | → Overweight |
| 05/05/2023 | 10.3% | Citigroup | $22 → $19 | Maintains | Buy |
| 05/04/2023 | 4.5% | Stephens & Co. | → $18 | Reiterates | → Overweight |
| 05/04/2023 | 33.53% | JMP Securities | → $23 | Reiterates | → Market Outperform |
| 04/13/2023 | -18.72% | Barclays | $17 → $14 | Maintains | Equal-Weight |
| 03/23/2023 | -12.92% | Keybanc | $18 → $15 | Maintains | Overweight |
| 02/24/2023 | 27.72% | Citigroup | $18 → $22 | Maintains | Buy |
| 02/24/2023 | 16.11% | Needham | → $20 | Reiterates | → Buy |
| 01/20/2023 | 4.5% | Keybanc | $16 → $18 | Maintains | Overweight |
| 09/15/2022 | 4.5% | Stephens & Co. | → $18 | Initiates Coverage On | → Overweight |
| 08/04/2022 | -7.11% | Barclays | $15 → $16 | Maintains | Equal-Weight |
| 08/04/2022 | 16.11% | Needham | $17 → $20 | Maintains | Buy |
| 07/07/2022 | 4.5% | Keybanc | $20 → $18 | Maintains | Overweight |
| 06/21/2022 | 4.5% | Citigroup | $32 → $18 | Maintains | Buy |
| 05/09/2022 | -12.92% | Barclays | $17 → $15 | Maintains | Equal-Weight |
| 05/06/2022 | -1.31% | Needham | $22 → $17 | Maintains | Buy |
| 02/24/2022 | 27.72% | Needham | $40 → $22 | Maintains | Buy |
| 01/25/2022 | 16.11% | Keybanc | $35 → $20 | Maintains | Overweight |
| 01/19/2022 | 10.3% | Barclays | $33 → $19 | Maintains | Equal-Weight |
| 12/14/2021 | 132.22% | JP Morgan | $62 → $40 | Maintains | Overweight |
| 11/08/2021 | 103.19% | Keybanc | $50 → $35 | Maintains | Overweight |
| 11/05/2021 | 132.22% | Needham | $50 → $40 | Maintains | Buy |
| 10/13/2021 | 91.58% | Barclays | $40 → $33 | Maintains | Equal-Weight |
| 05/10/2021 | 190.28% | Citigroup | → $50 | Initiates Coverage On | → Buy |
| 05/10/2021 | 190.28% | JMP Securities | → $50 | Initiates Coverage On | → Market Outperform |
| 05/10/2021 | — | William Blair | Initiates Coverage On | → Outperform | |
| 05/10/2021 | 143.83% | Goldman Sachs | → $42 | Initiates Coverage On | → Neutral |
| 05/10/2021 | 172.86% | Barclays | → $47 | Initiates Coverage On | → Equal-Weight |
| 05/10/2021 | 190.28% | Keybanc | → $50 | Initiates Coverage On | → Overweight |
| 05/10/2021 | 190.28% | Needham | → $50 | Initiates Coverage On | → Buy |
What is the target price for Alkami Technology (ALKT)?
The latest price target for Alkami Technology (NASDAQ: ALKT) was reported by Barclays on July 14, 2023. The analyst firm set a price target for $18.00 expecting ALKT to rise to within 12 months (a possible 4.50% upside). 16 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Alkami Technology (ALKT)?
The latest analyst rating for Alkami Technology (NASDAQ: ALKT) was provided by Barclays, and Alkami Technology maintained their equal-weight rating.
When is the next analyst rating going to be posted or updated for Alkami Technology (ALKT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Alkami Technology, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Alkami Technology was filed on July 14, 2023 so you should expect the next rating to be made available sometime around July 14, 2024.
Is the Analyst Rating Alkami Technology (ALKT) correct?
While ratings are subjective and will change, the latest Alkami Technology (ALKT) rating was a maintained with a price target of $14.00 to $18.00. The current price Alkami Technology (ALKT) is trading at is $17.23, which is within the analyst's predicted range.